Search these posts for articles, publications, research studies & discussions relevant to Phoenix Technology Group products.

Research Blog

2019

Using the Phoenix MICRON™ IV to examine a potential treatment for disrupted retinal vasculature

Many eye diseases, including age-related macular degeneration, diabetic macular edema, cancer growth, and uveitis, involve disrupted blood vessel growth and leakage. Curing the leakage and growth helps modulate and treat the underlying disease. The Phoenix MICRON™ IV fundus camera allows for clear visualization of the rodent vasculature in bright field and with fluorescein angiography. Mirando

2019

Developing a unique, novel dry AMD model with the Phoenix MICRON laser injector

The most common cause of blindness in developed societies, age-related macular degeneration (AMD) robs the victim of the crucially important focused macular vision. While still devastating, wet AMD has a robust mouse model and the treatment option of anti-vascular endothelial growth factor (VEGF) subretinal injections. The Phoenix MICRON laser allows precise delivery of 532 nm

2019

ARVO 2019: Frogs, Glue and CNV

Another ARVO passed by in a blur of research, scientific discussions, and seeing science friends. If you came by our booth, thank you for swinging by to chat with the Phoenix team. If you didn’t get a chance, please let me know if you have any questions about the Micron system and look for our

2019

Industry Expert Leslie MacKeen Joins Phoenix Technology Group as Product Manager

MacKeen brings 28 years of imaging expertise in ophthalmic research and pediatric ophthalmic imaging and will drive product initiatives across both Research and Clinical imaging solutions Pleasanton, CA, USA, April 10, 2019  – Today, Phoenix Technology Group (Phoenix), a leading provider of advanced ophthalmic imaging solutions for researchers and clinicians, announces Leslie MacKeen has joined

2019

Phoenix MICRON CNV System used to test a novel treatment for age-related macular degeneration

In their paper, “Suppression of Choroidal Neovascularization by AAV-Based Dual-Acting Antiangiogenic Gene Therapy,” Askou et al develop an adeno-associated virus (AAV) treatment for age-related macular degeneration. Beautiful fluorescent fundoscopy performed with the Phoenix MICRON validated the success of the subretinal AAV injection, while precise choroidal neovascularization (CNV) induced by Phoenix laser burns confirmed that the

2019

Corneal Thickness Analysis using OCT

Corneal images taken with the Phoenix Micron IV OCT used for thickness analysis King et al, a consortium of researchers at a range of institutions, recently used the Phoenix Micron IV OCT to examine corneal thickness in their article, “Genomic locus modulating corneal thickness in the mouse identifies POU6F2 as a potential risk of developing

1 2 3 4